Portola Pharmaceuticals

Portola is a biopharmaceutical company focused on the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders and inflammation for patients who currently have limited or no approved treatment options.

Select Venture Capital & Financial Partners

Abingworth Management Advanced Technology Ventures AllianceBernstein Holding L.P Alta Partners Brookside Capital (an affiliate of Bain Capital) CIDC Frazier Healthcare Ventures Goldman Sachs IBT MPM Capital Prospect Venture Partners Sutter Hill Ventures T. Rowe Price Associates Teachers’ Private Capital (the private investment arm of Ontario Teachers’ Pension Plan)